Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Aug;77(8):4764–4768. doi: 10.1073/pnas.77.8.4764

Inhibition of Ca2+ accumulation in mitogen-activated lymphocytes: role of membrane-bound plasma lipoproteins.

D Y Hui, J A Harmony
PMCID: PMC349927  PMID: 6933524

Abstract

Low density lipoproteins (LDL) in which apoB is the only protein constituent inhibit lymphocyte activation induced by the mitogen phytohemagglutinin. LDL suppress primary induction events, most notably enhanced Ca2+ accumulation, which occur as a result of mitogen-triggered alterations of the lymphocyte plasma membrane. Receptors in the lymphocyte membrane--designated "immunoregulatory receptors"--recognize and bind apoB-LDL. Under conditions of receptor saturation, about 22,500 +/- 4500 LDL particles are bound to the lymphocyte surface at 4 and 37 degrees C. The dissociation constant, Kd, is 1.76 X 10(-7) M and is also independent of temperature. Suppression of phytohemagglutinin-induced 45Ca2+ accumulation by LDL is a receptor-dependent process: inhibition is contingent on attachment of LDL to the immunoregulatory receptors. This conclusion is supported by three lines of evidence. First, heparin restores the susceptibility of the lymphocytes to mitogenic challenge by displacing membrane-bound LDL. Second, the immnoregulatory potency of LDL correlates directly with the amount of LDL bound at the cell surface. Third, LDL-Sepharose complexes, which cannot be internalized by the cells, are as immunosuppressive as soluble LDL. This demonstrates that membrane-bound plasma lipoproteins influence the behavior of intact cells.

Full text

PDF
4764

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Averdunk R., Lauf P. K. Effects of mitogens on sodium-potassium transport, 3H-ouabain binding, and adenosine triphosphatase activity in lymphocytes. Exp Cell Res. 1975 Jul;93(2):331–342. doi: 10.1016/0014-4827(75)90458-9. [DOI] [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. Bilheimer D. W., Eisenberg S., Levy R. I. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972 Feb 21;260(2):212–221. doi: 10.1016/0005-2760(72)90034-3. [DOI] [PubMed] [Google Scholar]
  4. Brown M. S., Goldstein J. L. Receptor-mediated control of cholesterol metabolism. Science. 1976 Jan 16;191(4223):150–154. doi: 10.1126/science.174194. [DOI] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Camejo G. The structure of human density lipoprotein: a study of the effect of phospholipase A and trypsin on its components and of the behavior of the lipid and protein moieties at the air-water interphase. Biochim Biophys Acta. 1969 Mar;175(2):290–300. doi: 10.1016/0005-2795(69)90007-5. [DOI] [PubMed] [Google Scholar]
  7. Curtiss L. K., Edgington T. S. Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. J Immunol. 1977 Jun;118(6):1966–1970. [PubMed] [Google Scholar]
  8. Curtiss L. K., Edgington T. S. Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. J Clin Invest. 1978 May;61(5):1298–1308. doi: 10.1172/JCI109047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curtiss L. K., Edgington T. S. Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol. 1976 May;116(5):1452–1458. [PubMed] [Google Scholar]
  10. Eisen S. A., Wedner H. J., Parker C. W. Isolation of pure human peripheral blood T-lymphocytes using nylon wool columns. Immunol Commun. 1972;1(6):571–577. doi: 10.3109/08820137209022965. [DOI] [PubMed] [Google Scholar]
  11. Fielding C. J., Vlodavsky I., Fielding P. E., Gospodarowicz D. Characteristics of chylomicron binding and lipid uptake by endothelial cells in culture. J Biol Chem. 1979 Sep 25;254(18):8861–8868. [PubMed] [Google Scholar]
  12. Fisher W. R., Hammond M. G., Warmke G. L. Measurements of the molecular weight variability of plasma low density lipoproteins among normals and subjects with hyper- -lipoproteinemia. Demonstration of macromolecular heterogeneity. Biochemistry. 1972 Feb 15;11(4):519–525. doi: 10.1021/bi00754a006. [DOI] [PubMed] [Google Scholar]
  13. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  14. Ho Y. K., Brown S., Bilheimer D. W., Goldstein J. L. Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. J Clin Invest. 1976 Dec;58(6):1465–1474. doi: 10.1172/JCI108603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hoff H. F., Jackson R. L., Mao S. J., Gotto A. M., Jr Localization of low-density lipoproteins in atherosclerotic lesions from human normolipemics employing a purified fluorescent-labeled antibody. Biochim Biophys Acta. 1974 Jun 7;351(2):407–415. doi: 10.1016/0005-2795(74)90205-0. [DOI] [PubMed] [Google Scholar]
  16. Hui D. Y., Berebitsky G. L., Harmony J. A. Mitogen-stimulated calcium ion accumulation by lymphocytes. Influence of plasma lipoproteins. J Biol Chem. 1979 Jun 10;254(11):4666–4673. [PubMed] [Google Scholar]
  17. Hui D. Y., Harmony J. A. Erythrocyte spectrin alteration induced by low-density lipoprotein. J Supramol Struct. 1979;10(2):253–263. doi: 10.1002/jss.400100214. [DOI] [PubMed] [Google Scholar]
  18. Hui D. Y., Harmony J. A. Inhibition by low density lipoproteins of mitogen-stimulated cyclic nucleotide production by lymphocytes. J Biol Chem. 1980 Feb 25;255(4):1413–1419. [PubMed] [Google Scholar]
  19. Hui D. Y., Harmony J. A. Interaction of plasma lipoproteins with erythrocytes. I. Alteration of erythrocyte morphology. Biochim Biophys Acta. 1979 Feb 2;550(3):407–424. doi: 10.1016/0005-2736(79)90145-7. [DOI] [PubMed] [Google Scholar]
  20. Hui D. Y., Harmony J. A. Interaction of plasma lipoproteins with erythrocytes. II. Modulation of membrane-associated enzymes. Biochim Biophys Acta. 1979 Feb 2;550(3):425–434. doi: 10.1016/0005-2736(79)90146-9. [DOI] [PubMed] [Google Scholar]
  21. Innerarity T. L., Mahley R. W., Weisgraber K. H., Bersot T. P. Apoprotein (E--A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E--A-II) complex. J Biol Chem. 1978 Sep 10;253(17):6289–6295. [PubMed] [Google Scholar]
  22. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  23. Mahley R. W., Innerarity T. L. Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin/manganese precipitability. J Biol Chem. 1977 Jun 10;252(11):3980–3986. [PubMed] [Google Scholar]
  24. Mahley R. W., Innerarity T. L., Pitas R. E., Weisgraber K. H., Brown J. H., Gross E. Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. J Biol Chem. 1977 Oct 25;252(20):7279–7287. [PubMed] [Google Scholar]
  25. Morse J. H., Witte L. D., Goodman D. S. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins. J Exp Med. 1977 Dec 1;146(6):1791–1803. doi: 10.1084/jem.146.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pitas R. E., Innerarity T. L., Arnold K. S., Mahley R. W. Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc. Proc Natl Acad Sci U S A. 1979 May;76(5):2311–2315. doi: 10.1073/pnas.76.5.2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Reichl D., Myant N. B., Lloyd J. K. Surface binding and catabolism of low-density lipoprotein by circulating lymphocytes from patients with abetalipoproteinaemia, with observations on sterol synthesis in lymphocytes from one patient. Biochim Biophys Acta. 1978 Jul 25;530(1):124–131. doi: 10.1016/0005-2760(78)90132-7. [DOI] [PubMed] [Google Scholar]
  28. Röschlau P., Bernt E., Gruber W. Enzymatische Bestimmung des Gesamt-Cholesterins im Serum. Z Klin Chem Klin Biochem. 1974 Sep;12(9):403–407. [PubMed] [Google Scholar]
  29. Schmidt F. H., von Dahl K. Zur Methode der enzymatischen Neutralfett-Bestimmung in biologischem Material. Z Klin Chem Klin Biochem. 1968 May;6(3):156–159. [PubMed] [Google Scholar]
  30. Weisgraber K. H., Innerarity T. L., Mahley R. W. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem. 1978 Dec 25;253(24):9053–9062. [PubMed] [Google Scholar]
  31. Weller N. K. Visualization of concanavalin A-binding sites with scanning electron microscopy. J Cell Biol. 1974 Nov;63(2 Pt 1):699–707. doi: 10.1083/jcb.63.2.699. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES